KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Synthesis and Characterization of Antigen-Containing Bioconjugates Used to Probe and Modulate Autoimmunity

    Thumbnail
    View/Open
    Available after: 2019-12-31 (5.625Mb)
    Issue Date
    2018-12-31
    Author
    Leon, Martin Antonio
    Publisher
    University of Kansas
    Format
    143 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Chemistry
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Autoimmune diseases afflict a significant part of the world population and current treatments only treat symptoms or delay the progression of the disease. In the first chapter of this dissertation, an introduction into autoimmunity and current clinically available non-antigen-specific treatments was presented, along with an overview of the rise of antigen-specific immunotherapies (ASIT) as an improved strategy for the treatment of autoimmune diseases. Furthermore, a detailed background into the chemistry utilized in this work to construct novel antigen-specific probes as potential therapies for autoimmune disorders was also offered. A novel class of bioconjugates known as antigen-drug conjugates (AgDCs) have been developed in our group. AgDCs utilize a similar directing strategy as antibody-drug conjugates (ADCs), which use a protein or peptide autoantigen (vehicle) to direct a conjugated drug (payload) to antigen-specific immune cells. Thus, AgDCs are a novel ASIT that may be used to treat autoimmune disorders. Chapter 2 is focused on the synthesis of various chemical biology tools, and the synthetic optimization of ‘clicking’ a modified-mimotope or a synthetic epitope to a potent drug via copper-catalyzed cycloaddition (CuAAC). This work also explored another potential novel therapeutic known as Soluble Antigen Arrays (SAgAs) developed in our group. SAgAs are constructed by using a hydrophilic linear polymer, hyaluronic acid (HA), grafted with multiple repeating autoantigen. SAgA technology introduced tolerance and suppressed disease in several studies in the mouse model of Multiple Sclerosis. SAgAs were also designed for flexibility in accommodating other autoantigens and for facilitating screening of antigen valency effects. Two new type of SAgAs were constructed and characterized using different Type 1 Diabetes autoantigens, namely p79 (chapter 3) and human insulin (chapter 4). Both cSAgAp79 and SAgAIns were tested in vitro to determine if the SAgAs are able to modulate immunological systems.
    URI
    http://hdl.handle.net/1808/29299
    Collections
    • Chemistry Dissertations and Theses [336]
    • Dissertations [4475]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps